These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 10768059)
1. [The clinical efficacy of augmentin (amoxicillin/clavulanate) in treating inflammatory diseases of the urogenital organs]. Tkachuk VN Antibiot Khimioter; 2000; 45(3):9-11. PubMed ID: 10768059 [TBL] [Abstract][Full Text] [Related]
2. [A trial of using augmentin (amoxicillin/clavulanate) in surgical practice]. Briskin BS; Khachatrian NN; Sosnovikova OG Antibiot Khimioter; 2000; 45(3):4-6. PubMed ID: 10768057 [TBL] [Abstract][Full Text] [Related]
3. [The use of augmentin (amoxicillin/clavulanate) in the postoperative period in patients with infectious-inflammatory diseases of the ENT organs]. Luchsheva IuV; Kriukov AI; Petrovskaia AN Antibiot Khimioter; 2000; 45(3):12-4. PubMed ID: 10768060 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group. Damrikarnlert L; Jauregui AC; Kzadri M J Chemother; 2000 Feb; 12(1):79-87. PubMed ID: 10768519 [TBL] [Abstract][Full Text] [Related]
5. [The augmentin (amoxicillin/clavulanate) prophylaxis of postoperative infectious complications in patients with acute surgical diseases of the abdominal cavity organs]. Grinberg AA; Gusiatin SN Antibiot Khimioter; 2000; 45(3):7-8. PubMed ID: 10768058 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections. Mehta AP; Phutane L; Patel MH; Rupwate RU; Kamat SR J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092 [TBL] [Abstract][Full Text] [Related]
7. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection]. Fomina IP Antibiot Khimioter; 1997; 42(9):36-43. PubMed ID: 9412419 [No Abstract] [Full Text] [Related]
8. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group. Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis. Sethi S; Breton J; Wynne B Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290 [TBL] [Abstract][Full Text] [Related]
10. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431 [TBL] [Abstract][Full Text] [Related]
11. A blind parallel comparative study of the efficacy and safety of rovamycin versus augmentin in the treatment of acute otitis media. Mgbor NC; Umeh RE West Afr J Med; 2002; 21(2):117-20. PubMed ID: 12403032 [TBL] [Abstract][Full Text] [Related]
12. [Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections]. Nonikov VE; Konstantinova TD; Lenkova NI; Minaev VI; Ritchik LA Antibiot Khimioter; 1997; 42(10):15-8. PubMed ID: 9412397 [TBL] [Abstract][Full Text] [Related]
13. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs]. DvoretskiÄ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of lower respiratory tract infections in the elderly]. Komarova VP; Belousov IuB; Sokolov AV; Tishchenkova IF; Efremenkova OV Antibiot Khimioter; 1997; 42(12):19-24. PubMed ID: 9480649 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children. Cook RC; Zachariah J; Cree F; Harrison HE Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329 [TBL] [Abstract][Full Text] [Related]
16. [Coamoxiclav in the empirical monotherapy in outpatients with community acquired pneumonia]. Yakovlev SV; Leshchenko IV; Kolesnikov VV; Suvorova MP Antibiot Khimioter; 1997; 42(10):19-22. PubMed ID: 9412398 [TBL] [Abstract][Full Text] [Related]
17. [Augmentin in the clinical picture of infectious diseases]. Gracheva NM; Petrova MS; Avakov AA; Bobovnikova VT Antibiot Khimioter; 1992 Sep; 37(9):25-7. PubMed ID: 1444664 [TBL] [Abstract][Full Text] [Related]
18. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease. Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections. Moreillon P J Chemother; 1994 Apr; 6 Suppl 2():51-7. PubMed ID: 7799055 [TBL] [Abstract][Full Text] [Related]
20. [A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria]. Savitskaia KI; Nekhorosheva AG; Skala LZ; Nasonov VN; Solodilova OE; Shanina AG; Dutova EN Antibiot Khimioter; 1992 Sep; 37(9):29-33. PubMed ID: 1444666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]